CXCR4 and CCR7: Two eligible targets in targeted cancer therapy
- 22 July 2016
- journal article
- review article
- Published by Wiley in Cell Biology International
- Vol. 40 (9) , 955-967
Abstract
Cancer is one of the most common cause of death in the world with high negative emotional, economic, and social impacts. Conventional therapeutic methods, including chemotherapy and radiotherapy, have not proven satisfactory and relapse is common in most cases. Recent studies have focused on targeted therapy with more precise identification and targeted attacks to the cancer cells. For this purpose, chemokine receptors are proper targets and among them, CXCR4 and CCR7, with a crucial role in cancer metastasis, are being considered as desired candidates for investigation. In this review paper, the most important experimental results are highlighted on the potential targeted therapies based on CXCR4 and CCR7 chemokine receptors.Keywords
This publication has 138 references indexed in Scilit:
- The Role of Chemokine Receptor CXCR4 in the Biologic Behavior of Human Soft Tissue SarcomaSarcoma, 2010
- The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesotheliomaThe Journal of Pathology, 2010
- Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastasesClinical & Experimental Metastasis, 2007
- CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathwayBiochemical and Biophysical Research Communications, 2007
- Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human SubjectsAntimicrobial Agents and Chemotherapy, 2007
- Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4British Journal of Cancer, 2006
- CXCR4 expression mediates glioma cell invasivenessOncogene, 2006
- Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal CancerJNCI: Journal of the National Cancer Institute, 2005
- Targeted cancer therapyNature, 2004
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004